Investor Type | Firm |
Industries | Cannabis • Healthcare (& Wellness) • Life Science |
Investing | United States |
Investment Range | $21,480,000 - $21,480,000 |
Alumina Partners is a New York-based private investment partnership with a focus on emerging growth companies across distinct sectors, such as life sciences, technology, cannabis, and materials. The firm's approach is characterized by their commitment to sensible, responsive, accretive, non-predatory, and non-disruptive institutional investment, positioning themselves as principal investors supporting the growth of their portfolio companies. They offer flexibility and scalability in their investment offerings, which include equities, convertible securities, derivatives, and structured products, ensuring that terms are advantageous for both the firm and the issuers. Alumina's investment strategy is anchored in the strengthening of management teams, believing that success derives from capable leadership backed by strong capitalization. The Alumina team comprises experts with extensive experience in structured products, derivatives, venture incubation, and private equity, emphasizing their particular expertise in life sciences, tech, and the emerging cannabis industry, as well as growth-through-acquisition strategies. Their investment process prioritizes issuer-centric equity research, and their position management team brings institutional desk access and market intelligence to facilitate the full realization of their investees' potential. They pride themselves on their ability to quickly move from term sheet to closing and their high rate of repeat investment reflects the long-term relationships they maintain with issuers. Seeking non-control investments, Alumina prioritizes the empowerment of management teams within their portfolio companies, allowing them to leverage the investments to generate shareholder value. Alumina Partners is actively seeking opportunities to invest in emerging growth companies through vehicles like straight equity private placements, convertible securities, and prospectus offerings, and they capitalize on their experience with the unique challenges and opportunities within the emerging growth space to make informed and efficient investment decisions. With over 35 combined years of transactional experience, the firm is well-grounded in securities law and regulation, deal structure, capital market dynamics, risk management, and contingency planning. The team's background includes firsthand experience in starting, growing, and establishing businesses, enabling them to impart their vast knowledge to every issuer they engage with.